Company news: Doximity, Jazz Pharmaceuticals

September 06 2012

Doximity adds $17 to its pool of funds, Jazz sells its line of women's health products for $95 million

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.